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Abstract
Background: Developmental effects of exposure to endocrine disruptors can influence adult
characters in mammals, but could also have evolutionary consequences. The aim of this study was
to simulate an environmental exposure of an experimental population of mice to high amounts of
nutritional phytoestrogens and to evaluate parameters of relevance for evolutionary change in the
offspring. The effect of a continuous pre- and post-natal exposure to high levels of dietary
isoflavones was evaluated on sexual maturity, morphometric parameters and DNA methylation
status in mice. Adult mice male/female couples were fed ad libitum either with control diet
(standard laboratory chow) or ISF diet (control diet plus a soy isoflavone extract at 2% (w/w) that
contained the phytoestrogens genistein and daidzein). In the offspring we measured: i) the onset of
vaginal opening (sexual maturation) in females, ii) weight and size in all pups at 7, 14, 21 and 42 days
post-natal (dpn) and iii) DNA methylation patterns in skeletal α-actin (Acta1), estrogen receptor-
α and c-fos in adults (42 dpn).
Results: Vaginal opening was advanced in female pups in the ISF group, from 31.6 ± 0.75 dpn to
25.7 ± 0.48. No differences in size or weight at ages 7, 14 or 21 dpn were detected between
experimental groups. Nevertheless, at age 42 dpn reduced size and weight were observed in ISF
pups, in addition to suppression of normal gender differences in weight seen in the control group
(males heavier that females). Also, natural differences seen in DNA methylation at Acta1 promoter
in the offspring originated in the control group were suppressed in the ISF group. Acta1 is known
to be developmentally regulated and related to morphomotric features.
Conclusion: This study demonstrates in mammals that individuals from a population subjected to
a high consumption of isoflavones can show alterations in characters that may be of importance
from an evolutionary perspective, such as epigenetic and morphometric characters or sexual
maturation, a life history character.
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Background
The evolutionary origin of new characters in a lineage is
considered to be a process different from that of mainte-
nance of these characters through generations [1,2].
Embryonic development plays an important role in the
origin of viable phenotypic variation, on which natural
selection may act further, thus, from an evolutionary per-
spective it is important to understand morphogenic proc-
esses taking place during early development [3].
Morphological transformations throughout evolutionary
history have been produced from context-dependent
changes in genetic processes that occur during develop-
ment [4]. Considering the genome as responsive to envi-
ronment has led to the hypothesis from us and others that
development and/or epigenetics can provide sources of
variation that are dependent on the environmental con-
text [5-7]. Moreover epigenetic status in adulthood is
directionally dependent on the animal's nutritional status
during early development [8,9]. Nevertheless, few studies
until recently have devoted attention to environmental
compounds that could directly influence early changes
implicated in the origin of new characters. Endocrine dis-
ruptors (ED) are among those compounds, since they are
capable of driving or inducing the occurrence of new char-
acters and/or phenotypes during early development.
Endocrine disrupting environmental chemicals may func-
tion as estrogens, antiestrogens and antiandrogens, pro-
ducing reproductive and developmental effects in a
variety of organisms [10]. Furthermore, exposure to envi-
ronmental xenobiotics during early development may
have consequences on adult stages [10,11]. In this study
we evaluated the effect of dietary exposure to high levels
of phytoestrogens on sexual maturity, morphometric
parameters and DNA methylation status in mice offspring
to determine the potential evolutionary consequences of
exposure to a phytoestrogenic based diet in an experimen-
tal population of mice.
During embryogenesis, the fetal microenvironment is sus-
ceptible to maternal influences due to dietary compounds
[12] or changes in maternal hormonal state [13]. Indeed,
the maternal hormonal state can be influenced by dietary
consumption of natural compounds with estrogenic
effects found in vegetables, such as phytoestrogens [14].
Daidzein and genistein are phytoestrogens naturally avail-
able (sometimes in high quantities) in food items com-
monly present in mammals' natural diets such as fruits,
nuts or seeds [15], but specially wheat, oats and soy
[15,16]. In humans, isoflavone consumption in Asian
countries (25 to 100 mg/day) is much higher than in west-
ern countries, such as UK, for example, with daily con-
sumption below 1 mg [17]. Mouse commercial diets may
contain levels of 21 mg of genistein plus 14 mg of daid-
zein per 100 g of diet [18], which corresponds to con-
sumption of approximately 1.4 mg of isoflavones/day.
Acting early during development, exogenous estrogenic
compounds may also play a role in producing modifica-
tions during key stages of ontogeny in mammals [5], hav-
ing consequences on population traits such as mate
preference [19] or life-history traits such as sexual matura-
tion [20]. For example, in mice, prenatal treatment with
the synthetic estrogen bisphenol-A (BPA) affects timing of
sexual maturation as the number of days between vaginal
opening and first vaginal estrous is significantly reduced
[20]. Morphological alterations can also be produced in
adults due to exposure to estrogenic compounds early
during ontogeny. Takai et al. [21] have shown that blasto-
cysts exposed to the synthetic estrogen BPA produce adult
mice that are heavier at weaning than controls, despite
having similar weight at birth. Natural estrogenic com-
pounds, such as genistein, have also been studied, and
produce the opposite effect on body mass. For example,
rodents fed the phytoestrogen genistein between 1 and 5
days post-natal gave birth to pups with lower post-puberty
body weights [14]. In humans, studies on early effects of
phytoestrogen consumption are scarce. However, phy-
toestrogen consumption may delay breast development
[22] and would have a protective effect against breast can-
cer [23]. Nevertheless, the effect may be protective only if
the exposure is during childhood/adolescence and would
occur through upregulation of breast cancer tumor sup-
pressors such as BRCA1 [24]. It is interesting to highlight
that transmission of isoflavones from mother to child has
been reported in humans [25].
There are many ways by which EDs can regulate gene
expression to produce phenotypic changes, [26-28], one
of which is epigenetic regulation [29]. For example, EDs
have the ability to induce alterations in DNA methylation
patterns on key genes and produce related transcriptional
changes [30,31]. EDs are capable of triggering changes in
DNA methylation during the development of organs. For
example, Li et al [32] demonstrated that neonatal expo-
sure to DES (diethylstilbestrol) produced abnormalities
in the demethylation of the lactoferrin promoter. Moreo-
ver, DES administration to pregnant rats during early
post-implantation development have been shown to pro-
duce a greater susceptibility for specific tumor formation
in the rete testis and reproductive tract tissues in F1, which
reappears in the non-exposed F2, suggesting epigenetic
alterations due to maternal exposure to EDs [33].
Recently, Dolinoy et al. [34] have shown that maternal
BPA treatment decreases the offspring's CpG DNA meth-
ylation in an intracisternal A particle retrotransposon
upstream of the Agouti promoter, resulting in a change in
the phenotype in the coat color pattern. Interestingly, die-
tary supplementation of the BPA treatment with methyl
donors or genistein inhibits the hypomethylating effect of
BPA, producing the same coat color pattern observed in
the controls [34]. Imprinted genes have also been shownBMC Physiology 2008, 8:17 http://www.biomedcentral.com/1472-6793/8/17
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to be target of EDs action. In vitro exposure of preimplan-
tation embryos to the contaminant 2,3,7,8-tertra-chlorod-
ibenzo-p-dioxin can alter DNA methylation in the H19
and IGF-2 imprinted genes [35]. Other examples of poten-
tial epigenetic modifications due to the action of EDs are
those occurring in germ line cells during differentiation.
Exposure of rat mothers to either vinclozolin or methoxy-
chlor during embryonic days 8 to 15 produces transgener-
ational defects in the spermatogenic capacity, which are
shown to be transmitted throughout four generations (F1
to F4) and also alteration in methylation patterns in the
F1 [36]. Exposure not only to synthetic estrogens but to
phytoestrogens has also been shown to influence epige-
netic change. For example administration of coumestrol
and equol to newborn mice can enhance methylation and
produce inactivation of the proto-oncogene H-ras [37],
and DNA methylation patterns is altered in 8-week-old
mice that consumed high doses of genistein [38]. More
recently, Dolinoy et al. [39] showed that maternal dietary
genistein supplementation of mice during gestation
shifted the coat color of heterozygous yellow agouti off-
spring toward pseudoagouti, which is associated with
changes in methylation patterns in that gene.
The aim of our study was to simulate an environmental
condition of exposure to high amounts of nutritional phy-
toestrogens on an experimental population of mice and to
evaluate potentially important characters for evolutionary
change as consequence of such exposure. We investigated
population and epigenetic effects on offspring after expo-
sure to an environmental estrogen through treating mice
with a continuous pre- and post-natal diet high in phy-
toestrogens. Life history characters were assessed in the
offspring, such as female sexual maturation (measured as
the onset of vaginal opening) and offspring sex ratio. Mor-
phometric characters such as weight and size were also
measured in all pups. CpG methylation profiles were
measured in the promoter region of the skeletal α-actin
(Acta1), estrogen receptor-α (ERα) and c-fos, in pancreas
and liver of the offspring born from both treatment
groups. Liver is an important non classical target for estro-
gens, in addition to the classic estrogenic response of
reproductive organs [40], and is implicated in non dia-
betic endocrine disorders [41]. In pancreas, in turn, meth-
ylation pattern alterations in proto-oncogenes have been
reported due to treatment of newborn mice pups with
phytoestrogens [37]. Genistein, through an estrogen
receptor mediated action, has been reported to modulate
gene expression in a variety of tissues in male mice
throughout development [42]. ERα has been reported to
be responsive to in utero signalling in mice, since maternal
arsenic exposure correlates with increased ERα expression
and reduced ERα promoter DNA methylation in the adult
offspring [43]. Acta1  is developmentally regulated and
associated with morphometric features in mouse [44] and
the promoters associated with both Acta1 and ERα show
tissue specific DNA methylation heterogeneity [45,46]. c-
fos, in turn, is a protooncogene and know to have an estro-
gen response element that binds the estrogen receptor
[47,48] and that may be a key factor in relating estrogenic
stimuli to methylation changes [5]. Therefore, we have
selected these three different gene promoter regions as
surrogate markers to measure if DNA methylation pat-
terns could be altered, during development, by high levels
of isoflavones in the maternal diet before and during ges-
tation.
The present paper shows that exposure of an experimental
mouse population to nutritional phytoestrogens in the
form of an isoflavone extract (not purified phytoetrogens)
can advance vaginal opening in female pups, reduce size
and weight in adult offspring and suppress normal gender
differences in weight seen in controls (males heavier that
females). Also, natural gender differences seen in DNA
methylation at the Acta1 promoter in the offspring born
in the control group were suppressed in the group con-
suming a diet high in isoflavones (ISF diet). This study
demonstrates that individuals from a mammalian popu-
lation subjected to a high consumption of isoflavones can
show altered characters, which are relevant from a evolu-
tionary perspective, such as epigenetic and morphometric
characters or sexual maturation as a life history character.
Methods
Experimental treatments
Adult mice (Mus musculus) C3H strain from a lab stock
population were initially raised in individual plastic cages
on a standard laboratory chow diet for rodents (Cham-
pion® S.A., Santiago, Chile) and water ad libitum (control
diet). Mice were randomly assigned in male/female cou-
ples to one of following experimental treatments: mice
were fed with i) control diet or ii) control diet plus a com-
mercial concentrate of soy isoflavones (ISF) (Soy Life®,
Netherlands B. V.) added at 2% (w/w), the ISF diet. To
ensure high levels of plasmatic isoflavones in mice fed on
the ISF diet, treatment was initiated two weeks before
placing the male and female couples in the same cage. The
proportion of soy isoflavone concentrate in the diet was
chosen considering a previous study [49] in which post
weaning long-term consumption of meals with as high as
2.4% soy extract produced significant agonistic effects in a
variety of estrogen-dependent tissues and reproductive
parameters in female rats, in addition to advancing the
age of vaginal opening. Isoflavone concentration in Con-
trol and ISF diets (showed in Table 1) was determined by
chromatographic analysis as previously described [50]. In
both experimental treatments, animals were fed ad libitum
and maintained at a light cycle of 12:12 at 22 ± 2°C. To
avoid maternal cannibalism, pups were not handled untilBMC Physiology 2008, 8:17 http://www.biomedcentral.com/1472-6793/8/17
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the age of 7 days post-natal (dpn) when gender identifica-
tion was performed in each litter.
Population characters evaluation
The time of the onset of vaginal opening, expressed as
dpn, was used to measure sexual maturation in females.
All female pups were examined daily after the age of 20
dpn to check occurrence of vaginal opening. Morphomet-
ric parameters such as weight, size and ano-genital dis-
tance were measured in all pups at 7, 14, 21 and 42 dpn.
The Student's t test or Two-way ANOVA was used as statis-
tical test. Two-way ANOVA were used in those compari-
sons in which diet and gender were tested as independent
variables. Statistical analyses were performed with Statis-
tica 6.0 (Statsoft®). All protocols used in the present study
were approved by the Institutional Animal Care and Use
Committee at INTA (Instituto de Nutrición y Tecnología
de los Alimentos), Universidad de Chile.
Animal euthanasia
The offspring used to obtain DNA from pancreas and liver
were euthanized after the age of 42 days. All sacrifices
were performed according to procedures recommended
by the 2000 Report of the American Veterinary Medicine
Association (AVMA) Panel on Euthanasia [51]. Animals
were placed in a glass chamber with CO2 and maintained
until 1 minute after no vital signs were observed. Cervical
dislocation was then performed to ensure the animal was
dead.
DNA isolation and bisulphite treatment
DNA was extracted with Wizard®  DNA Extraction Kit
(Promega) from liver and pancreas of adult mice born to
females previously assigned to one of the experimental
treatments. Bisulphite treatment of DNA was carried out
as previously described by Clark et al. [52] and Clark and
Frommer [53], with modifications described in Warnecke
et al. [54] and Clark et al. [55]. The process of bisulphite
treatment exploits the different sensitivities of cytosine
and 5-methylcytosine to deamination by bisulphite under
acidic conditions, in which cytosine undergoes conver-
sion to uracil, whereas 5-methylcytosine remains unreac-
tive [55]. The bisulphite reaction was desalted using a
DNA clean-up column (Promega), as instructed by manu-
facturer. Bisulphite treated DNA from liver and pancreas
was eluted in 50 μl H2O.
PCR conditions
For Acta1, the amplified region in the promoter ranged
from 529–785, numbers corresponding to GenBank
accession no. M12347, as previously reported [45]. CpG
site distances to the starting of transcription are shown in
(Fig. 1a). Nested PCR primers used were: forward external,
5'-AAGTAGTGATTTTTGGTTTAGTATAGT-3'; reverse exter-
nal, 5'-ACTCAATAACTTTCTTTACTAAATCTCCAAA-3';
forward internal, 5'-GGGGTAGATAGTTGGGGA-
TATTTTT-3'; reverse internal, 5'-CCTACTACTCTAACTC-
TACCCTAAATA-3'.
For ERα, the amplified fragment in the promoter was in
the 5' flanking region (in the untranslated exon C) [56]
and ranged from 282–608, numbers corresponding to
GeneBank accession no. AJ276597. CpG site distances to
the start of the first translated exon are shown in (Fig. 2).
The following semi-nested PCR primers were used: for-
ward external, 5'-GAGTTTTTTTTAGGAATGTTGATTTT-3';
forward internal, 5'-GGAGGGGTTGTTAAGTGTTTT-3';
reverse, 5'-ACACAACTTCCTTCTCCAACTAAAAA-3'.
For c-fos, the amplified fragment in the promoter region
ranged from 226–669, numbers corresponding to
GeneBank accession no. V00727. The following semi-
nested PCR primers were used: forward, 5'-AGGGGTAGA-
TATTGGTGGGAGTTGT-3'; reverse external, 5'-CTACAC-
CCTCAAAATTAACTACAACC-3'; reverse internal, 5'-
CCTCCTTTACACAAAATATCCATATTAAA-3'.
PCR reactions were performed in a final volume of 20 μl,
containing 10 μl 2× Promega master mix, 7 μl dnase free
water, 1 μl of each reverse and forward primers and 1 μl of
bisulphite treated DNA template (~40 ng of DNA). PCR
was programmed as follows: 94°C/2 min × 1 cycle; 94°C/
1 min, annealing temperatute/1 min, 72°C/3 min, × 5
cycles; 94°C/0.5 min, annealing temperatute/2 min,
72°C/1.5 min, × 25 cycles; 72°C/2 min × 1 cycle. Anneal-
ing temperatures were, 55°C for both rounds of amplifi-
cation for Acta1; 63°C for the first round primers (forward
external and reverse) and 59°C for the second round
primers (forward internal and reverse) for ERα; 60.5°C
for the first round primers (forward and reverse external)
and 59°C for the second round primers (forward and
reverse internal) for c-fos. All PCR reactions were per-
formed in triplicate for each tissue sample.
Table 1: Isoflavone composition of the experimental diets used in this study
Daidzein Genistein Total isoflavones
Control diet 32.06 mg/100 g 15.4 mg/100 g 47.46 mg/100 g
ISF diet 160.89 mg/100 g 38.92 mg/100 g 199.81 mg/100 gBMC Physiology 2008, 8:17 http://www.biomedcentral.com/1472-6793/8/17
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(a) scheme shows the distribution of CpG sites in the region analyzed for methylation changes in the promoter of Acta1 and  their distance to the starting of transcription, describing also the sequence analyzed Figure 1
(a) scheme shows the distribution of CpG sites in the region analyzed for methylation changes in the promoter of Acta1 and 
their distance to the starting of transcription, describing also the sequence analyzed. (b) and (c) correspond to sequencing of 
PCR products amplified from bisulphite treated DNA that includes the 8 CpG sites analyzed, which are indicated with arrows. 
(b) shows electrophenograms with direct sequencing data and (c) shows raw data electrophenograms from which CpG DNA 
methylation was quantified; shown sequences were obtained with the reverse primer; CpG sites in the forward strand appear 
in the reverse strand as CG when methylated and as CA when unmethylated.
7 8 6 5 4
5 4 6 7
a) Scheme and sequence of the α α α α-Actin CpG sites analyzed:
b) Example of direct sequence data:
c) Example of raw data :
-102 -62 -57 -39 -215 -205 -151 -147
12 3 4 5 6 7 8
5’CTCCATATACGGCCTGGTCCGGTCCTAGCTACCTGGGCCAGGGCAGTCCTCTCCTTCTTTGG
TCAGTGCAGGAGACCCGGGCGGGACCCAGGCTGAGAACCAGCCGAAGGAAGGGACTCTAGT
GCCCGACACCCAAATATGGCTTGGGAAGGGCAGCAACATTCTTCGGGGCGGTGTGGGGAGAG
CTCCCGGGACTATATAAAAACCTGTGCAAGGGGACAGGCGGTCACACGGACGTAAGCCTCA3’
1 2
34
5 6 7
8BMC Physiology 2008, 8:17 http://www.biomedcentral.com/1472-6793/8/17
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DNA sequencing
PCR products were purified by the Exo-Sap method (Exo-
nuclease I and Shrimp Alkaline Phosphatase from Amer-
sham Biosciences). The sequencing reactions were
performed by using the Dye Terminator cycle sequencing
kit with AmpliTaq DNA polymerase FS (Applied Biosys-
tems) and the automated 373A NA Sequencer (Applied
Biosystems). DNA methylation profiles were analyzed by
direct semi-quantitative bisulphite PCR sequencing [55].
The height of the cytosine peak relative to the thymine
peak was used to calculate the percentage of methylation
for each CpG site as previously described [55,57]. Analysis
of the direct PCR sequencing data was performed on raw
data electrophenograms (Figures 1b and 1c) in order to
improve the sensitivity of the methylation detection.
Measurements of raw data peak heights were performed
either manually or using the BioEdit Sequence Alignment
Editor (Isis Pharmaceuticals, Inc) [58], which permits a
fast and accurate measurement of the peak heights. This
approach has recently been used to address methylation
differences in a recent study [59]. We also cloned and
sequenced some of the PCR amplicons to confirm the
methylation patterns observed with direct sequencing
measured through raw data [see Additional file 1]. We
used multivariate ANOVA (MANOVA) to test for changes
in methylation. The multivariate approach tests for gen-
eral changes; when this is significant, univariate approach
tests for CpG site punctual effects. Statistical analyses were
performed with Statistica 6.0 (Statsoft®).
Results
Effect of a diet of soy isoflavones on sexual maturation 
and morphometric parameters
The content of the isoflavones genistein and daidzein
were measured in both experimental diets supplied to
mice and is shown in Table 1. Mice fed a continuous diet
of isoflavones (ISF diet) displayed no difference to the
control groups in sex ratio or litter size. Average sex ratio
Scheme shows the distribution of CpG sites in the region analyzed for methylation changes in the promoter of ERα, the dis- tance to the starting of transcription of the first translated exon and the sequence analyzed; the region includes 6 CpG sites Figure 2
Scheme shows the distribution of CpG sites in the region analyzed for methylation changes in the promoter of 
ERα, the distance to the starting of transcription of the first translated exon and the sequence analyzed; the 
region includes 6 CpG sites.
5’TCCACACACGCTCTGCCTTGATCACACACCGCGCCACTCG
ATCATTCGAGCACATTCCTTCCTTCCGTCTTACTGTCTCAGC
CCTTGACTTCTACAAACCCATGGAACATTTCTGGAAAGA3’
12 3 4
5 6
-2125 -2157 -2135 -2133 -2116 -2096
12 3 4 56BMC Physiology 2008, 8:17 http://www.biomedcentral.com/1472-6793/8/17
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of males found in litters born to parents treated with the
ISF diet was 49.4 % ± 5.8 (n = 12) and in litters born to
parents fed on control diet was 53.2 % ± 4.6 (n = 13) (val-
ues expressed as means of % of males per litter ± SE; P =
0.63). Litter size values were 8.1 ± 0.69 (n = 12) for the ISF
group and 8.5 ± 0.58 (n = 13) for the control group (val-
ues expressed as means of litter size ± SE; P = 0.68). How-
ever, sexual maturation was advanced by approximately 6
days in female pups born to ISF-fed mothers, with vaginal
opening occurring at 25.7 dpn ± 0.48 (n = 32) as com-
pared to 31.6 dpn ± 0.75 (n = 39) in the control group
(values expressed as mean day of vaginal opening ± SE; P
< 0.001) (Figures 3a and 3b). Not surprisingly, weight,
size and ano-genital distance in females at the day of vag-
inal opening were also reduced in the ISF feeding group.
Weight changed from 17.9 g ± 0.11 (n = 39) to 12.6 g ±
0.09 (n = 32), size from 8.1 cm ± 0.08 (n = 39) to 7.2 cm
± 0.14 (n = 32), and ano-genital distance from 6.6 mm ±
0.45 (n = 39) to 5.8 mm ± 0.54 (n = 27) (all values are
expressed as mean ± SE; P < 0.001 for all comparisons).
Such decreases are presumably associated with the
reduced age at which females mature.
When pooling males and females, no differences were
detected in the offspring among experimental groups in
size or weight at ages 7, 14 or 21 dpn. However, reduced
size (P = 0.03) and weight (P = 0.06) (2-way ANOVA; nISF
= 19, nCONTROL = 24) were observed at age 42 dpn in the
ISF group (Fig. 4a). Contribution of both sexes variation
account for size differences observed, as shown in Figure
4b, because no significant changes were detected inde-
pendently for each gender (males, P = 0.09, Students t test;
nISF = 9, nCONTROL = 12; females, P = 0.19, Students t test;
nISF = 10, nCONTROL = 12). Weight differences, in turn, are
accounted for by variations only in males (P = 0.04, Stu-
dents t test; nISF = 9, nCONTROL = 12), but not in females (P
= 0.8, Students t test; nISF = 10, nCONTROL = 12), as seen in
Figure 4c. Thus, normal gender differences in weight seen
in the control group (males heavier that females, P  <
0.001; Student's t test; nFEMALES = 12, nMALES = 12; Fig. 4c,
right) are suppressed in the ISF group (P = 0.3; Student's t
test; nFEMALES = 10, nMALES = 9; Fig. 4c, left). Finally, no dif-
ferences were detected among experimental groups in
ano-genital distance for either males or females.
Effect of dietary soy isoflavones on DNA methylation
We determined the methylation profile of 8 CpG sites for
Acta1 (Fig. 1a), 6 CpG sites for ERα (Fig. 2) and 18 CpG
sites for c-fos by using direct bisulphite DNA sequencing
across their promoter regions, in both liver and pancreas
from male and female pups born to mice fed on ISF and
control diets. We previously have shown that this region
of  Acta1  exhibits DNA methylation heterogeneity [45]
and therefore is a good candidate to evaluate if the paren-
tal diet can result in a tissue or gender specific effect on
DNA methylation of the offspring. ERα, in turn, has been
reported to be responsive to maternal exposure in terms of
changes in methylation [43]. c-fos is a protooncogene that
has an estrogen response element that binds the estrogen
receptor [47,48] and may be important in relating estro-
genic stimuli to methylation changes [5].
For Acta1, MANOVA showed no differences in DNA meth-
ylation in liver between pups born to mothers fed with the
ISF or the control diet when comparisons were performed
within males (Wilks Lambda: F = 0.1, P = 0.6; nISF = 5,
nCONTROL = 5), within females (Wilks Lambda: F = 10.2, P
= 0.2; nISF = 5, nCONTROL = 4; Fig. 5a) or pooling male and
female data (Wilks Lambda: F = 1.37, P = 0.3; nISF = 10,
nCONTROL = 9). Nevertheless, overall and individual CpG
site specific differences in Acta1 DNA methylation that
were seen between males and females in the control diet
fed mice (Wilks Lambda: P = 0.055; Univariate analysis:
site 2, F = 10.55, P = 0.015; site 4, F = 25.41, P = 0.0015;
site 6, P = 0.015, F = 10.55; site 7, F = 35.6, P = 0.0006;
nFEMALES = 4, nMALES = 5; Fig. 5b) were suppressed in the ISF
group (Wilks Lambda: F = 1.81, P = 0.4; nFEMALES = 5,
nMALES = 5; Fig. 5c). This could be explained by a subtle
decrease in the level of methylation in ISF males together
with a subtle increase in the level of methylation in ISF
females.
For Acta1 in pancreas, MANOVA revealed no gender dif-
ferences in the control group (Wilks Lambda: F = 0.2, P =
0.93, Fig. 6a; nFEMALES = 3, nMALES = 5) or in the ISF group
(Wilks Lambda: F = 0.42, P = 0.837, Fig. 6b; nFEMALES = 5,
nMALES = 5). Also, no differences were observed between
experimental groups within males (Wilks Lambda: F =
0.5, P = 0.804) or females (Wilks Lambda: P = 0.196, F =
14.83). Pooling male and female data together (Fig. 6c),
however, revealed a nearly significant difference with the
multivariate approach (Wilks Lambda: F = 2.698, P  =
0.08; nISF = 10, nCONTROL = 8), suggesting that overall
changes in methylation are taking place in Acta1 from
pancreas. This is reinforced by the fact that two CpG site
specific changes in methylation were detected, in sites
CpG5 (F = 11.168, P = 0.004) and CpG8 (F = 4.726, P =
0.045), showing increased levels of methylation in the ISF
group with respect to the control group. Additionally, we
compared the level of methylation between pancreas and
liver, using only control animals (both males and
females), in order to address the occurrence of tissue spe-
cific DNA methylation for Acta1. We found that methyla-
tion is increased in liver regarding to pancreas (Wilks
Lambda: F = 3.509, P = 0.047; Univariate analysis: CpG2,
F = 6.431, P = 0.022; CpG5, F = 11.727, P = 0.004; CpG8,
F = 9.926, P = 0.007; Fig. 6d; n = 8).
For ERα promoter, the methylation profile of 6 CpG sites
located from -2285 to -1979 was analyzed (Fig. 2). InBMC Physiology 2008, 8:17 http://www.biomedcentral.com/1472-6793/8/17
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Timing of female mice sexual maturation observed in the offspring of a population of mice subjected to ISF or control diet,  expressed as (a) distribution of occurrence of vaginal opening along days after birth and as (b) mean day of occurrence of vag- inal opening after birth ± SE ± 1,96*SE (P < 0.001) Figure 3
Timing of female mice sexual maturation observed in the offspring of a population of mice subjected to ISF or control diet, 
expressed as (a) distribution of occurrence of vaginal opening along days after birth and as (b) mean day of occurrence of vag-
inal opening after birth ± SE ± 1,96*SE (P < 0.001).
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Comparison of morphometric parameters between pups 42 days old Figure 4
Comparison of morphometric parameters between pups 42 days old. Variation in adult weight and size observed in 
the offspring of a population of mice subjected to ISF or control diet is shown. (a) indicates the general trend of decreased size 
(P = 0.03, *) and weight (P = 0.06, #) in the ISF group with regard to controls, when pooling males and females. Size differences 
in (a) are explained by variations in both sexes, as shown in (b). Weight differences in (a) are accounted for by variations only 
in males, which are heavier in the control group than in the ISF group (P = 0.04, ‡), as can be seen in (c). Also, in the control 
group males are heavier that females (P < 0.001; c, right, ±), difference that is suppressed in the ISF group (P = 0.3; c, left).
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Methylation profiles of the analyzed region of the Acta1 promoter in liver from offspring generated in the control or ISF group Figure 5
Methylation profiles of the analyzed region of the Acta1 promoter in liver from offspring generated in the con-
trol or ISF group. No differences in DNA methylation in liver were detected among treatments when comparisons were 
performed pooling male and female data (P = 0.3), as shown in (a). Nevertheless, gender methylation differences seen in (b), 
the controls (P = 0.0006), are suppressed in (c), the ISF group (P = 0.4). Significant changes in individual CpG sites are shown 
with *, P values are indicated in the text.
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Methylation profiles of the analyzed region of the Acta1 promoter in pancreas from offspring generated in the control or ISF  group Figure 6
Methylation profiles of the analyzed region of the Acta1 promoter in pancreas from offspring generated in the 
control or ISF group. DNA methylation gender differences are not observed in the population maintained on (a), control 
diet (P = 0.93), or on (b) ISF diet (P = 0.837). Nevertheless, pooling male and female data together shows a nearly significant 
difference due to the ISF treatment (P = 0.08), in which CpG site specific changes were detected in sites 5 (P = 0.004) and 8 (P 
= 0.045), as seen in (c), indicated with *. Using only control animals (both males and females) we found that methylation is 
increased in liver regarding to pancreas (P = 0.007), which shows the occurrence of tissue specific differences in DNA methyl-
ation for Acta1, as seen in (d).
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liver, MANOVA showed no gender differences in the ISF
group (Wilks Lambda: F = 1.86, P = 0.326; nFEMALES = 5,
nMALES = 4) or in the control (Wilks Lambda: F = 8.98, P =
0.1; nFEMALES = 4, nMALES = 5). Also, no multivariate effects
of the treatment were detected within males (F = 2.054, P
= 0.49; nISF = 4, nCONTROLS = 5), within females (F = 1.49,
P = 0.56; nISF = 5, nCONTROLS = 4) or pooling male and
female data (F = 2.054, P = 0.49; nISF = 9, nCONTROLS = 9)
(Figures 7a–c).
In addition, we found tissue specific DNA methylation
differences for ERα, where CpG sites were differentially
methylated in liver (Figures 7a–c), but completely
unmethylated in pancreas in both experimental groups (n
= 4). A lack of methylation across the promoter of c-fos
was observed in the liver and pancreas for both the ISF
and control animals (n = 4) (data not shown).
Our data has demonstrated that a diet rich in phyoestro-
gen can result in an advancement of sexual maturation in
female pups as well suppress normal gender differences in
the DNA methylation pattern of a tissue specific methyl-
ated gene such as Acta1. These results support the hypoth-
esis that alterations in the hormonal state of the pregnant
females produced by a diet of phytoestrogens or other
xenoestrogens can affect phenotype as well as the epige-
netic state of the offspring.
Discussion
The present study evaluated aspects related to morphol-
ogy, life-history traits and epigenetic modifications in
DNA methylation in the offspring of an experimental
population of mice subjected to a high dietary consump-
tion of isoflavones. We previously hypothesized that treat-
ment with dietary isoflavones could alter the hormonal
microenvironment where the fetus develops, which
could, in turn, trigger changes in early development, lead-
ing to phenotypic and population changes, which under
certain conditions may have evolutionary relevance [5]. If
a given environmental compound is persistently present
generation after generation in a population of individuals,
it may lead to a consistent altering of parameters and char-
acters in that population [29].
In this study we first evaluated sex ratio, a life-history trait,
in offspring exposed to the ISF diet, since previous evi-
dence has demonstrated that early hormonal exposure to
different levels of testosterone can induce sex ratio altera-
tions in litters [60]. In contrast, we did not find significant
differences in the percent of males in litters between the
control and ISF groups, suggesting that eventual effects of
phytoestrogens do not interfere with the mechanisms of
sex determination. Another life-history character analyzed
was female sexual maturation. We found that maternal
exposure to dietary isoflavones advanced puberty in
female offspring. This result confirms and complements
what other studies have found in mice. For example, a
similar trend was observed with prenatal treatment with
BPA, which is shown to reduce the days between the onset
of vaginal opening and the first vaginal estrous [20].
Another study that included phytoestrogens in the diet
between 15–30 days post partum, showed advanced vagi-
nal opening [61]. In rats, the age at vaginal opening was
also reported to be reduced due to dietary consumption of
isoflavones after weaning [49]. Although further studies
should be performed in order to clarify when advance-
ment in sexual maturation is triggered (before or after
birth, or before or after weaning), these data suggest that
perinatal phytoestrogen dietary consumption is an impor-
tant factor in advancing sexual maturation in females
rodents.
Steroid-mediated maternal effects in viviparous organ-
isms may also have long-lasting consequences on life-his-
tory aspects of the offspring and be an important
evolutionary factor [62]. Sexual maturation is an impor-
tant life-history character in animal populations, and
when changed, may lead to altered population structure
composition. Compared to other life history traits,
changes in the timing of sexual maturation strongly
impact on fitness [63]. For example, organisms in which
sexual maturation occurs earlier have a high probability of
surviving to maturity. Advanced age of maturity will also
produce shorter juvenile periods [63] and shorter genera-
tions [63,64]. Although timing of maturation is thought
to evolve as a consequence of selective pressures [63],
which implies restrictive environmental forces acting on
organisms, here we show that the environment, rather
than restricting the ontogeny of organisms, can act induc-
ing changes in life-history traits, which may also lead to
population and evolutionary changes. Figure 8 illustrates
how the structure of a population, expressed in terms of
reproductive periods, may be affected by an environmen-
tal stimulus such as dietary isoflavones. Moreover, if both
the stimulus and the induced population changes are con-
served throughout generations, an evolutionary change
could be expected [5].
Regarding morphometric aspects, we found that male
pups born within the ISF group have reduced weight and
size in comparison to the control group, at the age of 42
dpn. This is concordant with results found by Nagao et al.
[14] that show lower body weight in mice pups born to
mothers injected with the phytoestrogen genistein. Our
results however, show the opposite effect of that reported
by Takai et al. [21], in which culturing blastocytes in pres-
ence of the synthetic estrogen BPA resulted in heavier
pups at weaning, as compared to controls. This could be
due to the source of the estrogen (natural or synthetic)
employed in these studies. It is likely that environmentalBMC Physiology 2008, 8:17 http://www.biomedcentral.com/1472-6793/8/17
Page 13 of 19
(page number not for citation purposes)
Methylation profiles of the analyzed region of the ERα promoter in liver from offspring generated in the control or ISF group Figure 7
Methylation profiles of the analyzed region of the ERα promoter in liver from offspring generated in the con-
trol or ISF group. No treatment effects were detected within males, within females or pooling male and female data, as seen 
in (a), (b) and (c).
ERα α α α CpG sites analyzed in liver
0%
20%
40%
60%
80%
01234567
ISF diet
Control diet
0%
20%
40%
60%
80%
123456
y
c) Pooled data Females + Males
1 2 3 4 5 6 1 2 3 4 5 6
ISF diet
Control diet
ISF diet
Control diet 60%
80%
40%
20%
0%
P
e
r
c
e
n
t
 
o
f
 
M
e
t
h
y
l
a
t
i
o
n
0%
20%
40%
60%
80%
Males
Females
0%
20%
40%
60%
80%
b) ISF diet
1 2 3 4 5 6 1 2 3 4 5 6
Males
Females
Males
Females 60%
80%
40%
20%
0%
P
e
r
c
e
n
t
 
o
f
 
M
e
t
h
y
l
a
t
i
o
n
ERα α α α CpG sites analyzed in liver
0%
20%
40%
60%
80%
0 1 2 3 4 5 6 7
Males
Females
0%
20%
40%
60%
80%
123 4 5 6
P
e
r
c
e
n
t
 
o
f
 
M
e
t
h
y
l
a
t
i
o
n
 
a) Control diet
1 2 3 4 5 6 1 2 3 4 5 6
Males
Females
Males
Females 60%
80%
40%
20%
0%
P
e
r
c
e
n
t
 
o
f
 
M
e
t
h
y
l
a
t
i
o
n
ERα α α α CpG sites analyzed in liverBMC Physiology 2008, 8:17 http://www.biomedcentral.com/1472-6793/8/17
Page 14 of 19
(page number not for citation purposes)
estrogens, such as genistein, would produce effects other
than those produced with synthetic estrogens, such as
BPA. The mechanism behind the weight and size differ-
ences could either be due to epigenetic or physiological
changes. The sex specific effect in weight shown here may
be related to testosterone levels, since a strong correlation
between body mass and testosterone levels is known to
exist. For example, serum testosterone is about 9.6-fold
higher in mice selected for high body weight [65]. Inter-
estingly, phytoestrogens are shown to reduce the conver-
sion from androgens to estrogens through inhibiting
aromatase activity in human granulose-luteal cell cultures
[66,67], which will produce imbalances in the testoster-
one/estradiol ratio. Further investigation should be done
in order to elucidate if this male related weight response
to phytoestrogens is dependent on testosterone produc-
tion.
Taking into consideration the hypothesis that there is an
epigenetic basis for the differences in weight as a result of
ISF treatment, we could expect that these gender-specific
differences in weight and size could be related to gender-
specific changes in DNA methylation. We analyzed the
promoter region of Acta1 as a surrogate marker for DNA
methylation change, as we previously reported that regu-
lation of this gene is associated with tissue specific DNA
methylation [45]. In this new study we found that the
consumption of high amounts of dietary phytoestrogens
by mice mothers can lead to sex-specific changes in DNA
methylation patterns of the Acta1 promoter, specifically in
the liver. Interestingly, we discovered that there is a natu-
ral difference between males and females in Acta1 pro-
moter DNA methylation, as males showed higher levels of
methylation than females. Treatment with dietary isofla-
vones appears to suppress such gender differences,
decreasing the level of DNA methylation in males and/or
increasing it in females. These findings pose an intriguing
question in terms of what is the mechanism behind the
gender differences in DNA methylation. In addition to the
differences observed in liver, we also found that DNA
methylation changes occurred in the pancreas. As
expected, we found that methylation of Acta1 in pancreas
shows a different tissue-specific profile than in liver, as
previously reported in Warnecke & Clark [45]. However,
analysis of male and female pooled DNA samples showed
increased methylation in response to ISF treatment in two
CpG sites in pancreas, CpG5 and CpG8, suggesting that
there is a potential sequence-specific and tissue-specific
Scheme showing two hypothetical population structures subjected to different consumption of dietary isoflavones Figure 8
Scheme showing two hypothetical population structures subjected to different consumption of dietary isofla-
vones.
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effect as a result of diet. Tissue specific differences in meth-
ylation profiles were also detected for ERα, which show
absence of methylation in pancreas, contrasting with a
well-defined methylation profile seen in liver. The pheno-
typic consequences of changes in methylation in the Acta1
promoter could be related to the changes in male weight.
Crawford et al. [44] showed that null Acta1 mice die in the
early neonatal period and, moreover, 4 days after birth
they show a markedly lower body weight than normal lit-
termates. Although the phenotypic effect of DNA methyl-
ation in males is not expected to be as drastic as that seen
in Acta1 null mice, we could expect that altering DNA
methylation in the Acta1  promoter in some organs in
males could contribute to body weight reduction.
Considering these aspects, the main question is 'what is
the mechanism through which the intrauterine environ-
ment could influence DNA methylation in developing
embryos?' We have previously hypothesized that phytoes-
trogenic influences could take place either directly,
through the presence of isoflavones in uterine secretions,
or indirectly, mediated by other compounds secreted in
the uterine epithelia such as 4-OH-17β-estradiol,
responding to circulating levels of isoflavones [5]. It is not
known whether compounds with estrogenic action, like
isoflavones, inside the uterus could act directly upon the
developing embryo. Nevertheless, it is possible that the
relationship between such estrogenic stimuli and methyl-
ation in the preimplantational embryo is mediated by the
expression of c-fos. It has been reported that c-fos directly
regulates the transcription of the DNA maintenance meth-
yltransferase gene, Dnmt1, increasing the enzyme levels
[68]. On the other hand, the induction of c-fos is attrib-
uted to membrane-mediated estrogen actions [69].
Through this mechanism, which provides an alternative
pathway to the classical estrogen receptors α and β, estro-
genic compounds could trigger responses, as has been
observed in pancreatic β cells [70]. Thus, the membrane-
mediated estrogenic actions would first induce c-fos and
then trigger the activation of the Dnmt1 enzyme. Further-
more, in blastocysts, this indirect and membrane medi-
ated mechanism of c-fos activation could also occur. In
preimplantational blastocysts, latent blastocysts can be
activated in presence of 4-OH-17β-estradiol, a catecholes-
trogen synthesized from 17β-estradiol in uterine luminal
epithelia by the action of the hydrogen-2/hydroxylase-4
enzyme [71]. This response to 4-OH-17β-estradiol could
also occur via a pathway distinct from the classical nuclear
estrogen receptors [71]. Levels of 4-OH-17β-estradiol
increase with the epithelial growth factor (EGF) receptor
[71]. Interestingly, other studies have demonstrated that
an increase in the EGF receptor may also be related to acti-
vation of c-fos [72]. A direct induction of c-fos by estrogen
has also been shown in different cell types [73,74], which
occurs via an estrogen receptor element present in this
gene [47]. Thus, estrogenic stimuli could induce c-fos,
either directly, through a gene receptor, or indirectly
through membrane-mediated reactions. Figure 9 summa-
rizes the possible pathways for the estrogenic stimulus to
influence DNA methylation in developing embryos.
Taking this background into consideration, we analyzed
DNA methylation in the promoter region of c-fos, but
found that the c-fos promoter was unmethylated. There-
fore, if c-fos expression is regulated by an estrogenic stim-
ulus it is possible that methylation is not involved in its
regulation, but this does not exclude the possibility that i)
other mechanisms of epigenetic regulation may be occur-
ring, since for example, changes in chromatin structure or
histone modifications may also be affected following
estrogenic stimuli [29] and that ii) c-fos can still be acting
as a mediator in the process of methylation of other genes.
The involvement of EDs in the process of DNA methyla-
tion is also supported by the finding that exposure of early
embryos to TCDD, DES, or PCB 153 alters the DNA meth-
yltransferase activity, which has the potential to induce a
change in methylation status of genes and to affect further
developmental processes [75]. Thus, the link relating EDs
(including phytoestrogens) and DNA methylation is gain-
ing increased support. Future work should be performed
in order to investigate if other genes are altered in their
DNA methylation patterns as a result of isoflavones expo-
sure or other environmental signals capable of acting
across the uterine barrier and affecting the developing
embryo. Particularly interesting would be the study of the
de novo and maintenance DNA methyltransferases. How-
ever, future focus should take into consideration that
changes in methylation may be sex-specific.
Conclusion
The present study demonstrates, in mammals, that a pop-
ulation subjected to a high consumption of isoflavones
can show a variety of alterations in its individuals, includ-
ing changes in epigenetic and morphometric characters
and in sexual maturation. The results obtained here,
together with previous reports in the field ([8], [12-14],
[21], [23-26], [28-31], [41], [57], [58]), start to reveal
important facts about the role of EDs (including natural
compounds such as phytoestrogens) on altering epige-
netic mechanisms such as DNA methylation. Consump-
tion of compounds such as phytoestrogens by pregnant
mothers may interfere with the establishment of DNA
methylation in the developing embryos, leading to a
change in DNA methylation and potential gene expres-
sion patterns in the resulting adults [5]. This is coincident
with the idea that heritable variation is sometimes
directed and developmentally produced as a response to
the environment [6].BMC Physiology 2008, 8:17 http://www.biomedcentral.com/1472-6793/8/17
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As shown here, exposure to environmental estrogens have
consequences on characters that are important from the
population structure point of view such as sexual matura-
tion. Moreover, ED-induced changes in DNA methylation
are interesting from an evolutionary perspective because
they could lead to biased mutations as consequences of
persistent changes in DNA methylation through genera-
tions. It is known, for example, that the methylated form
of CpG has a 12-fold higher mutation rate to TpG and
CpA [76]. Environmental stimuli could have a great
importance in inducing evolutionary change, although
some restrictions may apply in order for this process to
occur, as we have previously described [5]: i) environmen-
tal stimuli could act only on certain key periods in the
ontogeny of the organisms in order to produce epigenetic
effects; ii) not every but only particular environmental
agents acting as such stimuli would be able to produce
those epigenetic effects, and iii) a persistent genomic
change should be produced generation after generation in
a whole population exposed to such stimuli. That persist-
ent change could be achieved by a persistent action of the
stimuli, producing a consistent epigenetic change genera-
tion after generation, or by altering the genome through
mutations or epigenetic changes in imprinted genes,
which would express those changes in futures genera-
tions.
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